ThermalPass www.thermalpass.com, was prominently featured in an article on Fox.com last night titled, “As America reopens, fever-screening technology touted as promising tool.”
Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19
Revive Therapeutics is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders.
We are advancing our main programs in COVID-19 and psychedelics with the aim to initiate clinical studies in the short-term while leveraging our assets and building our pharmaceutical-based product pipeline for long-term growth,” said Michael Frank, Revive’s Chief Executive Officer
Kontrol Energy Launches Enterprise Software Pilots with Leading European Original Equipment Manufacturer
Kontrol has initiated two pilots with one of Europe’s largest manufacturers of HVAC equipment.